ATE109001T1 - Mittel zur stimulierung der tränensekretion. - Google Patents

Mittel zur stimulierung der tränensekretion.

Info

Publication number
ATE109001T1
ATE109001T1 AT89904439T AT89904439T ATE109001T1 AT E109001 T1 ATE109001 T1 AT E109001T1 AT 89904439 T AT89904439 T AT 89904439T AT 89904439 T AT89904439 T AT 89904439T AT E109001 T1 ATE109001 T1 AT E109001T1
Authority
AT
Austria
Prior art keywords
agents
tear secretion
stimulating tear
stimulating
secretion
Prior art date
Application number
AT89904439T
Other languages
English (en)
Inventor
Ronald D Schoenwald
Charles F Barfknecht
Original Assignee
Univ Iowa Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Iowa Res Found filed Critical Univ Iowa Res Found
Application granted granted Critical
Publication of ATE109001T1 publication Critical patent/ATE109001T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT89904439T 1988-03-16 1989-03-13 Mittel zur stimulierung der tränensekretion. ATE109001T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/168,680 US4820737A (en) 1987-02-17 1988-03-16 Lacrimal secretion stimulant (lss)

Publications (1)

Publication Number Publication Date
ATE109001T1 true ATE109001T1 (de) 1994-08-15

Family

ID=22612490

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89904439T ATE109001T1 (de) 1988-03-16 1989-03-13 Mittel zur stimulierung der tränensekretion.

Country Status (9)

Country Link
US (1) US4820737A (de)
EP (1) EP0363469B1 (de)
JP (1) JP2929384B2 (de)
KR (1) KR0135634B1 (de)
AT (1) ATE109001T1 (de)
AU (2) AU611021B2 (de)
CA (1) CA1328665C (de)
DE (1) DE68917071T2 (de)
WO (1) WO1989008452A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256698A (en) * 1987-02-17 1993-10-26 University Of Iowa Research Foundation Treatment of psychosis using cyclohexyl-phenyl-lower alkyl amine derivatives
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
AU1747992A (en) * 1991-03-29 1992-11-02 University Of Iowa Research Foundation, The Ophthalmic uses of sigma site binders
US5225424A (en) * 1992-10-21 1993-07-06 University Of Iowa Research Foundation Methazolamide-derived carbonic anhydrase inhibitors
AU6124494A (en) * 1993-01-28 1994-08-15 University Of Iowa Research Foundation, The Ophthalmic uses of signa agonists
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5322859A (en) * 1993-02-08 1994-06-21 University Of Iowa Research Foundation Antiglaucoma drug composition and method
US5387614A (en) * 1993-07-27 1995-02-07 University Of Iowa Research Foundation Use of sigma receptor ligands as salivary gland stimulants
US5961987A (en) * 1996-10-31 1999-10-05 University Of Iowa Research Foundation Ocular protein stimulants
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
WO2006089168A2 (en) * 2005-02-18 2006-08-24 Cornell Research Foundation, Inc. Methods for modulating ion channels
US9482677B2 (en) 2008-02-27 2016-11-01 Scios Inc. Method, composition and device for sampling natriuretic peptides in a biological fluid
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289787A (en) * 1977-12-19 1981-09-15 Eli Lilly And Company Quaternary ammonium antiarrhythmic drugs
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4407792A (en) * 1979-05-09 1983-10-04 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage

Also Published As

Publication number Publication date
AU8351491A (en) 1991-11-14
JP2929384B2 (ja) 1999-08-03
KR0135634B1 (ko) 1998-04-23
DE68917071D1 (de) 1994-09-01
WO1989008452A1 (en) 1989-09-21
JPH02503442A (ja) 1990-10-18
KR900700091A (ko) 1990-08-11
EP0363469A1 (de) 1990-04-18
EP0363469A4 (en) 1991-05-15
CA1328665C (en) 1994-04-19
DE68917071T2 (de) 1994-12-01
AU611021B2 (en) 1991-05-30
EP0363469B1 (de) 1994-07-27
AU3414289A (en) 1989-10-05
US4820737A (en) 1989-04-11

Similar Documents

Publication Publication Date Title
ATE109001T1 (de) Mittel zur stimulierung der tränensekretion.
DE1300150T1 (de) Prostaglandin-Derivate zur Behandlung von Glaukom oder Augenüberdruck
ES2180530T3 (es) Sulfonamidas de tiofeno utiles como inhibidores de anhidrasa carbonica.
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
DE3779346D1 (de) Zusammensetzung zur behandlung der haut.
SE7903186L (sv) Cerebralverksamt medel
NO158741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere.
FR2342072A1 (fr) Composition enzymatique pour le traitement de la cataracte
ES2154262T3 (es) Uso de compuestos macrolidos para enfermedades oculares.
FI915093A0 (fi) Sackarinderivat anvaendbara som inhibitorer foer proteolytiskt enzym och deras framstaellning.
ES2087160T3 (es) Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos.
DE3872701D1 (de) Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck.
ATE162074T1 (de) Oculare hypotensive mittel
KR900701323A (ko) 신규한 녹내장 치료용 안과 제제
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
ATE68182T1 (de) Thiophensulfonamide zur behandlung von glaukom.
ES2079068T3 (es) 2-amino-6-fenil-4h-piran-4-onas antiateroscleroticas y antitromboticas.
NO891894D0 (no) Fremgangsmaate for fremstilling av antikoagulerende peptidalkoholer.
DK0435177T3 (da) 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-oner samt deres anvendelse som antikonvulsive midler
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
ES2083636T3 (es) Componente adhesivo para la restauracion de la sustancia dental dura.
ES2014494B3 (es) Procedimiento para el tratamiento de material de fibra de celulosa coloreada
FI844645A0 (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
DE3787954D1 (de) Verwendung von 5-(Subst. Phenyl)- Oxazolidinonderivaten zur Behandlung von Depressionen.
NO890801D0 (no) Fremgangsmaate for fremstilling av lysyloxydaseinhibitorer.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee